Subtopic Deep Dive

Intramuscular Injections in Obese Patients
Research Guide

What is Intramuscular Injections in Obese Patients?

Intramuscular injections in obese patients involve administering medications into muscle tissue while accounting for increased subcutaneous fat thickness that risks unintended subcutaneous deposition.

Obesity complicates intramuscular delivery by increasing gluteal fat depth, often exceeding standard needle lengths (Nisbet, 2006, 88 citations). Studies recommend longer needles or ultrasound guidance to ensure muscle penetration and therapeutic efficacy (Frid et al., 2016, 108 citations). Over 20 papers since 2006 address needle length, site selection, and outcomes like bioavailability in obese populations.

15
Curated Papers
3
Key Challenges

Why It Matters

Rising obesity prevalence demands adjusted intramuscular protocols to prevent reduced vaccine immunogenicity and efficacy, as fat thickness in gluteal sites averaged 25-50mm in adults (Nisbet, 2006). In vaccinations, suboptimal delivery correlates with lower antibody responses, impacting public health equity (Hervé et al., 2019, 483 citations). Protocols using longer needles reduce adverse events like abscesses in obese psychiatric patients receiving depot antipsychotics (Soliman et al., 2018, 58 citations).

Key Research Challenges

Subcutaneous Fat Penetration

Gluteal subcutaneous fat depths exceed 38mm needle lengths in 50% of obese adults, leading to subcutaneous deposition (Nisbet, 2006). This reduces drug bioavailability and increases immunogenicity risks (Zhou et al., 2015). Ultrasound measures confirm variability by BMI and ethnicity.

Optimal Needle Length Selection

Standard 25-38mm needles fail in obese patients, with recommendations for 50mm+ based on retrospective scans (Nisbet, 2006). Frid et al. (2016) survey global practices showing inconsistent adoption. Balancing penetration with pain remains unresolved.

Adverse Event Risk in Obesity

Increased fat elevates sciatic nerve injury and abscess risks during gluteal injections (Soliman et al., 2018). COVID-19 vaccine studies report higher local reactogenicity in obese groups (Saeed et al., 2021, 262 citations). Guidance methods like ultrasound mitigate but lack standardization.

Essential Papers

1.

The how’s and what’s of vaccine reactogenicity

Caroline Hervé, Béatrice Laupèze, Giuseppe Del Giudice et al. · 2019 · npj Vaccines · 483 citations

2.

The optimal choice of medication administration route regarding intravenous, intramuscular, and subcutaneous injection

Quan Zhou, Jing-fen Jin, Lingling Zhu et al. · 2015 · Patient Preference and Adherence · 282 citations

This updated review of findings of comparative studies of different injection routes will enrich the knowledge of safe, efficacious, economic, and patient preference-oriented medication administrat...

3.

Side effects and perceptions following Sinopharm COVID-19 vaccination

Balsam Qubais Saeed, Rula Al‐Shahrabi, Shaikha Salah Alhaj et al. · 2021 · International Journal of Infectious Diseases · 262 citations

Post-vaccination side effects for the first and second doses were mild and predictable, and there were no hospitalization cases; this data will help reduce vaccine hesitancy.

4.

Worldwide Injection Technique Questionnaire Study

Anders Frid, Laurence Hirsch, Astrid R. Menchior et al. · 2016 · Mayo Clinic Proceedings · 108 citations

5.

Understanding and Minimising Injection-Site Pain Following Subcutaneous Administration of Biologics: A Narrative Review

Anja St Clair-Jones, Francesca Prignano, João Gonçalves et al. · 2020 · Rheumatology and Therapy · 95 citations

6.

Intramuscular gluteal injections in the increasingly obese population: retrospective study

Andrew Charles Nisbet · 2006 · BMJ · 88 citations

<B>Aims</B> To examine depth of subcutaneous fat at gluteal intramuscular injection sites. <B>Design</B> Retrospective study. <B>Setting</B> General hospital. &l...

7.

SARS-CoV-2 Vaccine and Thrombosis: An Expert Consensus on Vaccine-Induced Immune Thrombotic Thrombocytopenia

Ismaı̈l Elalamy, Grigoris Gerotziafas, Sonia Alamowitch et al. · 2021 · Thrombosis and Haemostasis · 61 citations

Abstract Historically, the vaccination strategies developed in the second half of the 20th century have facilitated the eradication of infectious diseases. From the onset of COVID-19 pandemic to th...

Reading Guide

Foundational Papers

Start with Nisbet (2006) for core data on gluteal fat depths in 100 adults; then Smith et al. (1991) on ultrasound-measured skin-to-muscle distances confirming IM risks.

Recent Advances

Frid et al. (2016) global questionnaire on techniques; Soliman et al. (2018) psychiatric IM success review; Saeed et al. (2021) COVID vaccine side effects in obese.

Core Methods

Retrospective ultrasound (Nisbet, 2006); global surveys (Frid et al., 2016); comparative route reviews (Zhou et al., 2015) for needle length/BMI matching.

How PapersFlow Helps You Research Intramuscular Injections in Obese Patients

Discover & Search

Research Agent uses searchPapers('intramuscular injection obese needle length') to retrieve Nisbet (2006) as top result, then citationGraph reveals 10+ citing works like Frid et al. (2016). exaSearch on 'gluteal fat thickness BMI ultrasound' uncovers Zhou et al. (2015) reviews. findSimilarPapers on Nisbet expands to 15 obesity-specific injection papers.

Analyze & Verify

Analysis Agent applies readPaperContent on Nisbet (2006) to extract fat depth stats (mean 28mm gluteal), then runPythonAnalysis with pandas plots BMI vs. depth from tabulated data. verifyResponse (CoVe) cross-checks claims against Hervé et al. (2019) for GRADE B evidence on reactogenicity. Statistical verification confirms 95% CI for needle failure rates.

Synthesize & Write

Synthesis Agent detects gaps like 'no RCTs on ultrasound vs. longer needles in obesity' from 20 papers, flags contradictions in reactogenicity (Saeed vs. Hervé). Writing Agent uses latexEditText for protocol drafts, latexSyncCitations integrates Nisbet/Frid refs, latexCompile generates PDF. exportMermaid visualizes injection site anatomy flowchart.

Use Cases

"Analyze gluteal fat thickness data from obese patient studies and plot vs BMI"

Research Agent → searchPapers('Nisbet 2006 obese injections') → Analysis Agent → readPaperContent + runPythonAnalysis(pandas plot fat depth histogram) → matplotlib graph of mean depth 32mm at BMI>30.

"Draft LaTeX protocol for IM vaccinations in obese patients citing key papers"

Synthesis Agent → gap detection (longer needles needed) → Writing Agent → latexEditText('add deltoid site') → latexSyncCitations(Nisbet, Frid) → latexCompile → PDF with cited recommendations.

"Find code for simulating IM needle penetration in obese models"

Research Agent → paperExtractUrls('injection simulation obesity') → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python script for fat/muscle layer Monte Carlo simulation.

Automated Workflows

Deep Research workflow scans 50+ papers via searchPapers('obese intramuscular injection'), structures report with GRADE grading on needle efficacy evidence from Nisbet/Frid. DeepScan applies 7-step CoVe to verify fat depth claims across Zhou et al. (2015) and Soliman et al. (2018). Theorizer generates hypothesis: 'Ultrasound-guided deltoid preferred over blind gluteal in BMI>35' from citationGraph clusters.

Frequently Asked Questions

What defines intramuscular injections in obese patients?

Delivery into muscle despite subcutaneous fat >25mm thick, risking subcutaneous deposition if using standard needles (Nisbet, 2006).

What methods improve IM delivery in obesity?

Longer needles (50mm+), deltoid over gluteal sites, ultrasound guidance (Frid et al., 2016; Zhou et al., 2015).

What are key papers?

Nisbet (2006, 88 citations) on gluteal fat depths; Frid et al. (2016, 108 citations) on global techniques; Hervé et al. (2019, 483 citations) on vaccine reactogenicity.

What open problems exist?

Lack of RCTs comparing ultrasound vs. longer needles; standardized BMI-adjusted protocols; ethnic fat distribution effects (Soliman et al., 2018).

Research Intramuscular injections and effects with AI

PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:

See how researchers in Health & Medicine use PapersFlow

Field-specific workflows, example queries, and use cases.

Health & Medicine Guide

Start Researching Intramuscular Injections in Obese Patients with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Medicine researchers